Tuesday, 2 October 2012

Wegener’s granulomatosis


A previously fit and well 31-year-old male patient requiring ventilation for severe respiratory failure characterised by haemoptysis and hypoxia was found to have diffuse pulmonary haemorrhage. He also tested positive for haematuria and proteinuria. His tests for c-ANCAs (classical antineutrophil cytoplasmic antibodies) were  positive, confirming the diagnosis of Wegener’s granulomatosis. Once the diagnosis has been made, which one of the following would be the PREFERRED drug therapy?

a) Cyclophosphamide i.v. 1 g/day
b) Methylprednisolone i.v. 30 mg/day
c) Ciclosporin i.v. 200 mg/day
d) Azathioprine i.v. 250 mg/day
e) Methotrexate i.v. 7.5 mg/week

Answer: a

Explanation

Even though both high dose intravenous steroids and cyclophosphamide are used in the acute management of organ-threatening Wegener’s granulomatosis, the answer to this question is cyclophosphamide as it is usually the specific definitive treatment for this condition and the dose of methylprednisolone is too low. Ciclosporin has been used in the management of patients with Wegener’s granulomatosis who have not been successfully treated with cyclophosphamide and steroids. Azathioprine and methotrexate are both used in the longer term management of Wegener’s granulomatosis, once the patient is in remission, as they are less toxic.

No comments:

Post a Comment